GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $1,947,000 | -87.6% | 45,143 | -87.6% | 2.39% | +134.2% |
Q2 2016 | $15,730,000 | +2.5% | 362,947 | -4.1% | 1.02% | +10.2% |
Q1 2016 | $15,346,000 | -2.8% | 378,469 | -3.2% | 0.93% | 0.0% |
Q4 2015 | $15,782,000 | +0.7% | 391,129 | -4.0% | 0.93% | +19.9% |
Q3 2015 | $15,667,000 | -9.2% | 407,454 | -1.7% | 0.77% | +3.2% |
Q2 2015 | $17,257,000 | +97.2% | 414,339 | +8.5% | 0.75% | +112.2% |
Q1 2015 | $8,750,000 | -59.9% | 381,930 | -25.2% | 0.35% | -60.2% |
Q4 2014 | $21,832,000 | -13.0% | 510,815 | -6.4% | 0.89% | -4.2% |
Q3 2014 | $25,084,000 | -16.3% | 545,668 | -2.6% | 0.92% | -8.9% |
Q2 2014 | $29,967,000 | -5.4% | 560,331 | -5.5% | 1.02% | +28.2% |
Q1 2014 | $31,665,000 | -8.4% | 592,639 | -8.5% | 0.79% | -7.6% |
Q4 2013 | $34,575,000 | +27.2% | 647,590 | +19.5% | 0.86% | +18.2% |
Q3 2013 | $27,187,000 | -37.3% | 541,893 | -37.6% | 0.72% | -44.3% |
Q2 2013 | $43,367,000 | – | 867,863 | – | 1.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |